Chemotherapy for small-cell lung cancer

H. Ueoka, K. Kiura, M. Tabata, A. Bessho, A. Matsushita, K. Chikamori, H. Yamane, M. Harada, I. Kimura, T. Ohnoshi

Research output: Contribution to journalArticlepeer-review


Here we review the current treatments for small-cell lung cancer. Cisplatin and etoposide, combined with concurrent or alternating thoracic irradiation, have been considered to be the standard therapy for patients with limited disease. Dose-intensive weekly chemotherapy and high-dose chemotherapy with autologous stem cell transplantation have failed to increase survival in patients with extensive disease. Promising new drugs such as irinotecan and taxol may improve survival in patients with extensive disease.

Original languageEnglish
Pages (from-to)87-91
Number of pages5
JournalJapanese Journal of Thoracic Diseases
Issue numberSUPPL.
Publication statusPublished - 1996


  • Chemotherapy
  • Dose-intensive chemotherapy
  • High-dose chemotherapy
  • Small-cell lung cancer
  • Thoracic irradiation

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine


Dive into the research topics of 'Chemotherapy for small-cell lung cancer'. Together they form a unique fingerprint.

Cite this